Brief: Aziyo Biologics Q2 revenue USD 10.296 million
14/08/2023 23:23
Aug 14 (Reuters) - Aziyo Biologics Q2 operating expenses USD 10.065 million. * Q2 net income USD -10.621 million * Q2 income from operations USD -9.085 million * Q2 revenue USD 10.296 million * Q2 gross profit USD 980 thousand
Recent news on Elutia
See all newsBrief: Elutia Receives $8 Million Payment From Boston Scientific Company Now Fully Funded Into 2029
Elutia Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Elutia Secures $15 Million Loan Financing From Avenue Capital Group
Elutia's Q2 revenue falls on SimpliDerm production disruption
Elutia Inc expected to post a loss of 15 cents a share - Earnings Preview